Dr. Brenner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MGH Center for Pain Medicine, WAC 334
15 Parkman Street
Boston, MA 02114Phone+1 617-726-9223Fax+1 617-724-3632
Education & Training
- Massachusetts General HospitalFellowship, Pain Medicine, 1999 - 2000
- Massachusetts General HospitalResidency, Anesthesiology, 1996 - 1999
- Highland Hospital of RochesterInternship, Internal Medicine, 1995 - 1996
- University of Rochester School of Medicine and DentistryPh.D., Microbiology & Immunology, 1991 - 1995
- University of Rochester School of Medicine and DentistryClass of 1995
- Wesleyan UniversityBA, Biology, 1982 - 1986
Certifications & Licensure
- MA State Medical License 1999 - 2025
- American Board of Anesthesiology Pain Medicine
Awards, Honors, & Recognition
- Boston Magazine - Top Doc in Pain Medicine Castle Connelly, 2010-2021
Publications & Presentations
PubMed
- 464 citationsNociceptors are interleukin-1beta sensorsAlexander M. Binshtok, Haibin Wang, Katharina Zimmermann, Fumimasa Amaya, Daniel Vardeh
The Journal of Neuroscience. 2008-12-24 - 389 citationsERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity.Ru-Rong Ji, Katia Befort, Gary J. Brenner, Clifford J. Woolf
The Journal of Neuroscience. 2002-01-15 - 642 citationsNociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity.Ru-Rong Ji, Hiroshi Baba, Gary J. Brenner, Clifford J. Woolf
Nature Neuroscience. 1999-11-29
Press Mentions
- Crowdsourcing to Fund Rare Disease ResearchJuly 6th, 2019
- Patient Story: Karen EnglishApril 22nd, 2019
- Mom Blazes Path to Cure for Son’s Rare DiseaseFebruary 27th, 2019
Grant Support
- Salmonella typhimurium-based Bacteriotherapy for Orphan Benign Tumors: Neurofibromatosis Type II (NF2)NIH - NINDS2019–Present
- Translation of AAV P0 ICE schwannoma gene therapy to clinical TrialsNIH2015–2018
- Mechanisms of caspase-1 mediated schwannoma regressionNIH2012–2017
- NMDA Receptor Phosphorylation And Trafficking After PainNational Institute Of Neurological Disorders And Stroke2002–2006
- Department Of Microbiology And ImmunologyNational Institute Of Mental Health1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: